進行性心不全患者の性差:HELP-HFのレジストリの分析
Mauro Riccardi1,2, Chiara Tedino2, Mauro Chiarito3,4
1Division of Cardiology, Cremona Hospital, Largo Priori Emilio, 1, Cremona 26100, Italy.
ESC heart failure
|February 19, 2026
まとめ
進行性心不全 (HF) の場合,男性と女性は異なる臨床プロファイルを示しますが,1年後の結果は似ています. この研究では,高度なHF患者の死亡率や入院の性別による有意な差異は認められませんでした.
科学分野:
- 心臓病学 心臓病学
- クリニック・リサーチ 臨床研究
- 医学における性差について
背景:
- 心不全 (HF) の性差は認められていますが,進行したHFの証拠は限られています.
- これらの違いを理解することは,臨床実務と患者のケアを最適化するために不可欠です.
研究 の 目的:
- 進行性心不全患者の臨床的特徴と1年間のアウトカムにおける性差異を調査する.
- 進行性HFの高リスクマーカーを有する患者の予後に影響を及ぼすかどうかを判断する.
主な方法:
- HELP-HFの登録には,イタリアの4つのセンターで,高度なHFマーカーを持つ1,149人の患者が含まれていました.
- 男性と女性の患者の人口統計,臨床データ,エコーカルディオグラフィの発見を比較した.
- 主要エンドポイントは,全因死亡率または1年以内に最初のHF入院の複合でした.
主要な成果:
- 男性 (67.3%) はより若い年齢で,心臓血管疾患が多く,エジェクション分数が低く,女性では非心臓疾患が多かった.
- 1年間の複合エンドポイントは,男性の43.2%と女性の43.1%で発生しました (P = .857).
- 多変量分析では,性による主なエンドポイント (aHR 1.03; P = .740) への有意な影響は示されなかった.
結論:
- 明確な臨床的およびエコーカルディオグラフィックプロファイルにもかかわらず,性はこの高度な心不全のレジスタリで1年間の結果に有意な影響を及ぼさなかった.
- これらの発見は,進行したHFと高リスクマーカーを有する患者の予後を決定する主な要因は性別ではないことを示唆しています.
さらに関連する動画
04:05Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure
Published on: June 30, 2023
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
関連する概念動画
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.